What 15 Analyst Ratings Have To Say About Neurocrine Biosciences
Portfolio Pulse from Benzinga Insights
In the last 3 months, 15 analysts have offered 12-month price targets for Neurocrine Biosciences (NASDAQ:NBIX), with an average price target of $123.0, a high of $150.00, and a low of $106.00. The average price target has increased by 0.55% over the past month.
June 05, 2023 | 9:01 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Neurocrine Biosciences (NASDAQ:NBIX) has received an average 12-month price target of $123.0 from 15 analysts, with a high of $150.00 and a low of $106.00. The average price target has increased by 0.55% over the past month.
The average 12-month price target for Neurocrine Biosciences has increased by 0.55% over the past month, indicating a positive sentiment among analysts. This could lead to a short-term increase in the stock price as investors may see this as a sign of confidence in the company's future performance.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100